Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 36.72 Delayed Data As of 4:00pm ET |  -0.25 / -0.68%Today’s Change | 18.70 Today|||52-Week Range 41.49 | +32.66% Year-to-Date |
Latest IOVA News | Press Releases
| Global Blood, Iovance and Reata Make Takeover List Oct 21 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 36.97 |
| Today’s open | 36.99 |
| Day’s range | 36.50 - 37.50 |
| Volume | 48,843 |
| Average volume (3 months) | 1,569,785 |
| Market cap | $5.3B |
Data as of 4:00pm ET, 10/22/2020
Growth & Valuation
| Earnings growth (last year) | -25.07% |
| Earnings growth (this year) | -22.38% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 15.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | +2.56 | +2.56% |
| NVAXNovavax Inc | +2.48 | +2.72% |
| ARWRArrowhead Pharmaceut... | +1.84 | +3.24% |
| EBSEmergent BioSolution... | +4.60 | +4.94% |
Data as of 4:19pm ET, 10/22/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$197.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
